LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 233 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $206,000 | -13.8% | 995 | -31.1% | 1.67% | +15.1% |
| Q1 2018 | $239,000 | +20.7% | 1,445 | 0.0% | 1.45% | +16.7% |
| Q4 2017 | $198,000 | +0.5% | 1,445 | 0.0% | 1.24% | +245.6% |
| Q3 2017 | $197,000 | +12.6% | 1,445 | 0.0% | 0.36% | +8.4% |
| Q2 2017 | $175,000 | +14.4% | 1,445 | 0.0% | 0.33% | +7.1% |
| Q1 2017 | $153,000 | +4.1% | 1,445 | 0.0% | 0.31% | -0.6% |
| Q4 2016 | $147,000 | -99.9% | 1,445 | 0.0% | 0.31% | +51.5% |
| Q3 2016 | $147,476,000 | +85641.9% | 1,445 | 0.0% | 0.21% | +46.1% |
| Q2 2016 | $172,000 | -99.9% | 1,445 | -33.9% | 0.14% | -4.7% |
| Q1 2016 | $233,991,000 | +98630.4% | 2,185 | 0.0% | 0.15% | +3.5% |
| Q4 2015 | $237,000 | +24.1% | 2,185 | -2.2% | 0.14% | +6.7% |
| Q3 2015 | $191,000 | +30.8% | 2,235 | +54.7% | 0.13% | +52.3% |
| Q2 2015 | $146,000 | – | 1,445 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 1,199,766 | $130,078,630,000 | 35.65% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 852,053 | $92,380,000 | 5.34% |
| OBERWEIS ASSET MANAGEMENT INC/ | 101,127 | $10,964,000 | 3.08% |
| Timpani Capital Management LLC | 68,160 | $7,390,000 | 3.00% |
| ASHFORD CAPITAL MANAGEMENT INC | 103,420 | $11,213,000 | 2.64% |
| First Light Asset Management, LLC | 56,818 | $6,160,000 | 2.58% |
| Conestoga Capital Advisors, LLC | 286,162 | $31,026,000 | 2.51% |
| OAK RIDGE INVESTMENTS LLC | 955,599 | $103,606,000 | 2.48% |
| RK Capital | 127,983 | $13,876,000 | 2.42% |
| Nichols Asset Management LLC | 93,170 | $10,101,000 | 2.20% |